Comprehensive Obesity-specific QOL/Control Outcome Test is first of Six New Disease-specific Short Forms
US 2025 population survey results support JWRG’s simpler aggregation of single-item-per-domain (SIPD) short forms that more practically capture 5 distinct disease-specific outcomes. Results confirm practicality of a new < 1-minute QOL/Control Test summary score and profile of 5 key obesity-specific outcomes and their responsiveness to clinically important differences across CDC/WHO defined body mass index (BMI) severity groups.
The first scientific presentation at the 32nd Annual ISOQOL Conference is also available online at:
This poster presentation introduces a new Obesity-specific QOL/Control Test, reports the first of six independent disease-specific evaluations of JWRG’s template for standardizing (across diseases) and aggregating (across key outcomes) single-item-per-disease (SIPD) measures for purposes of estimating a single summary test score and a profile of substantially related but distinct disease-specific outcomes.
In the current study, the following disease-specific outcomes were all measured with attribution specifically to “Obesity:”
- QOL impact severity,
- QOL impact frequency,
- Perceived Control,
- Severity Overall, and
- Symptom (Bodily pain)
Background
Although these five outcomes, particularly QDIS frequency and severity measures are frequently cited in studies of different chronic diseases, items have rarely been standardized and/or used in unison across chronic diseases prior to the Disease Impact CAT (DICAT) studies that launched QDIS in 2010 and continuing through the current 2025 study.
JWRG launched an NIH-funded innovative research disease impact measurement project that has evolved over the past 10 years into the shortest-possible single-item-per-domain (SIPD) short form for five essential disease-specific PRO’s.
Other prevalent chronic condition (asthma, diabetes, depression, low back pain and osteoarthritis) studies testing the generalizability of the JWRG QOL/Control Test are underway.
The QOL/Control Test uses the 5-category rating items for the five standardized disease-specific outcomes shown below with attribution specifically to one CONDITION; which was “Obesity” in the current study.
- QOL impact severity: In the past 4 weeks, how much did your <CONDITION>
limit your everyday activities or your quality of life? QOL impact frequency:* In the past 4 weeks, how often did your <CONDITION>- Not at all – Extremely
make you worn out or too tired to work or do daily activities? Severity, overall: How would you rate the severity of your <CONDITION>- Never – Very often
in the past 4 weeks? Perceived Control: How would you rate your control of your <CONDITION> during the past 4 weeks?- None – Very severe
- Not controlled at all – Well controlled
- Symptom: In the past 4 weeks, how much did being overweight cause you bodily pain?
- Not at all – Extremely
- *From 1-6 different QDIS-7 frequency items were evaluated as SIPD, different combinations of static multi-item and computerized adaptive test (CAT)-administered short forms.
- **Symptom item, which was unique to each condition, adhered to item stem attribution and response category conventions used successfully in legacy disease-specific measures.
This approach assumes that:
- Short forms are used more than more burdensome forms, and
- Representing valid outcome content with a SIPD item covering the observed score range is better than multiple items for any one outcome or score level.
Methods
Briefly, study methods evaluated practical issues, psychometric properties and the responsiveness of each key outcome and the summary QOL/Control Test score across groups known to differ in body mass index (BMI) criteria in important amounts defined by CDC/WHO for obesity severity groups.
Responses to cross-sectional 2025 online surveys of representative NORC samples of US general population adults (18-93 years, mean age = 48) were analyzed for those overweight (about 26%, N=595) according to body mass index (BMI) criteria recommended by CDC and WHO including different obesity severity groups. For those previously diagnosed with obesity (N=140), all five outcomes were surveyed.
Responses were analyzed to evaluate data quality, test-retest reliability (7-10 days) and to apply classical and CFA psychometric evaluations.
To evaluate validity in terms iof responsiveness to differences in BMI severity analysis of variance (ANOVA) comparisons (overall F-ratio and effect sizes) of mean scores were made across groups differing in BMI severity.
Results
In support of practicality and data quality, most respondents completed all test items in <1 minute and data completeness and test-retest reliability were satisfactory.
Results indicate that measures are (1) sufficiently psychometrically sound in both classical (reliability and construct validity) and CFA tests supporting the 1-factor higher-order model shown in the poster figure; and (2) are valid in responding to mean differences across CDC/WHO-defined BMI obesity severity levels (normal, overweight and three levels of obesity severity).
As summarized in the second poster figure, ANOVAs comparing mean scores across objectively defined CDC/WHO normal and overweight and obesity severity groups, responsiveness was demonstrated for the overall summary Test score and each of the five profile outcomes; all F-ratios confirming that total test and profile scores responded to differences across all group BMI levels of overweight and severity (p<0.001).
Illustrative profile comparisons also illustrate unique larger and smaller effect size patterns across obesity severity groups (e.g., two examples include loss of control occurring with the onset of obesity whereas differences in QOL impact are the greatest between the two highest BMI severity levels).
Additional comments
The value of PRO measurement standardization (both item content and scoring) has been demonstrated for both disease-specific and generic PROs as has the greater likelihood of usage of shorter form tools proven to measure them.
Current project methods broaden this logic to include SIPD measures of disease-specific severity, control and symptoms that have primarily been used previously for purposes of validating disease-specific QOL frequency and impact measures. Aggregated, they provide a simpler, more comprehensive summary test score that also enables all of the advantages of looking more specifically at each of its elements when analyzing this overall “barometer” of QOL/Control to better understand differences in disease burden or treatment benefit.
Conclusions:
Study results support the use of the current study standardized composite test aggregating patient-reported severity, QOL impact, and control.
Comprehensiveness and practicality: The 5-item, < 1-minute QOL, Control Test summarizes 5 key obesity outcomes while also enabling analysis of each outcome.
Even though disease-specific QOL severity and frequency, overall severity, control and symptom measures provide unique reliable information, they are sufficiently homogeneous to for purposes of a simple aggregate, reliable and valid summary score
Access the Test:
🌐QDIS items standardizing disease-specific QOL impact across obesity and dozens of other chronic conditions and scoring instructions are available from the non-profit Mapi Research Trust at
htps://eprovide.mapi-trust.org
verbatim items and other information are available at: https://jwrginc.com